What’s Behind the Scary-Good Box Office Holds for ‘Smile’ and ‘Barbarian’?
Rebecca Rubin Film and Media Reporter At the box office, horror movies have a tendency to run out of steam faster than a teenager being chased through the woods by a masked killer. Even the most successful scary stories are known to earn the bulk of their money in the first weekend of release. Yet “Smile” and “Barbarian,” two recent big-screen thrillers, have defied conventional wisdom by impressively sticking around in theaters after opening weekend. Ticket sales for “Smile,” in particular, nominally declined in between its first and second weekend of release, a sign of exceptionally positive word-of-mouth. Over the weekend, Paramount’s “Smile” retained the No. 1 spot in North America with $18 million, sliding just 18% from its $22 million start. At the international box office, something even crazier happened: “Smile” actually improved on its debut by 31%, bringing in $19.1 million in its second weekend. And it continues to flex during the week, adding $2.6 million domestically on Monday. After only 12 days in theaters, the movie is already nearing the coveted $100 million mark. It’s a bloody-good result for the $17 million-budgeted “Smile.”